GREENSBORO, North Carolina, May 28 -- The American Baseball Coaches Association issued the following news: * * * 2026 ABCA/Rawlings NCAA Div. III All-America Teams Announced The 2026 ABCA/Rawlings NCAA Div. III All-America teams were unveiled Thursday night during the Opening Ceremony of the NCAA Div. III College World Series in Eastlake, Ohio. This year's All-America selections include nine student-athletes competing in the 2026 NCAA Div. III College World Series. The ABCA/Rawlings All-Amer  more

ALBANY, New York, May 28 -- The New York State Department of Environmental Conservation issued the following news release: * * * DEC Announces Forest Management Project at Lafayetteville Multiple Use Area Upcoming Project will Support Regional Forest Bioeconomy, Regenerate Oak Tree Growth, and Enhance Wildlife Habitat * The New York State Department of Environmental Conservation (DEC) today announced an upcoming forest management project on the 715-acre Lafayetteville Multiple Use Area in t  more

BOSTON, Massachusetts, May 31 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * Perioperative Apalutamide in High-Risk Localized or Locally Advanced Prostate Cancer Reduces Risk of Metastasis and Death * High-risk localized and locally advanced prostate cancer patients treated with apalutamide -a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) -plus hormone therapy before and after prostate cancer surgery resulted in m  more

BOSTON, Massachusetts, May 31 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * RAS(ON) Inhibitor Doubles Median Overall Survival in Results of Phase 3 Trial for Patients with Metastatic Pancreatic Cancer * At the ASCO annual meeting, Dana-Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic cancer, r  more

LOS ANGELES, California, May 31 [Category: BizHospital] -- Cedars-Sinai, a nonprofit academic healthcare organization, posted the following news: * * * Study: New Drug Could Dramatically Increase Pancreatic Cancer Survival * A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in The New England Journa  more